Warfarin has remained the most commonly prescribed vitamin K oral anticoagulant
worldwide since its approval in 1954. Dosing challenges including having a narrow …

Abstract Purpose of Review To address the following question: Are vitamin K antagonists
(VKA) obsolete as stroke prevention therapy for patients with atrial fibrillation (AF) and …

Background We compared the dementia incidence rate between users and nonusers of oral
anticoagulants (OACs) in a large cohort of primary care patients with atrial fibrillation …

Background and Objectives Ischemic stroke despite a direct oral anticoagulant (DOAC) is
increasingly common and portends a high risk of subsequent ischemic stroke. The efficacy …

Die Arzneimitteltherapie bei Frauen im gebärfähigen Alter ist jedoch schlecht dokumentiert.
Das geht aus unseren Umfrageergebnissen hervor. Nur wenige Frauen, die bereits vor ihrer …

Objective The goal of this work is to evaluate if there is an increase in the risk of
thromboembolic events (TEEs) due to concomitant exposure to dexamethasone and …

Background There has been debate on the use of intravenous thrombolysis (IVT) in patients
with ischemic stroke and the recent use of direct oral anticoagulants (DOACs). Studies have …

Abstract Background Direct oral anticoagulants (DOACs) have a favourable risk-benefit
profile compared to vitamin K-antagonists (VKAs) in atrial fibrillation (AF). Dosing is based …

Arterial and venous thromboembolism are both more common in older adults. The use of
anticoagulants, the mainstay to prevent thromboembolism, requires consideration of the …

Background: Recent years have seen a change in the use of anticoagulants in the general
population due to the availability of direct oral anticoagulants (DOACs) as an alternative to …